Overview
- 185 inspections across 173 sites are on record.
- 434 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-10-31.
At a glance
Inspections
185
Sites
173
Observations
434
Career since
Jul 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Apex Display Group, LLC | 31 Oct 2025 | Human Drugs | On file |
| Nephron SC, LLC | 22 Aug 2025 | Human Drugs | On file |
| Human Genome Sciences Inc | 31 Jul 2025 | Human Drugs | On file |
| Blossom Pharmaceuticals | 11 Apr 2025 | Human Drugs | View 483 → |
| Emcure Pharmaceuticals Limited | 25 Feb 2025 | Human Drugs | On file |
Sites inspected
Apex Display Group, LLCLansdale, United States1 insp.
Nephron SC, LLCWest Columbia, United States1 insp.
Human Genome Sciences IncRockville, United States1 insp.
Blossom PharmaceuticalsBardej, Goa, India1 insp.
Emcure Pharmaceuticals LimitedPune, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Lori Gioia11 shared
Melva J Palmer6 shared
Brittany D Terhar6 shared
Shirley J Berryman5 shared
Yvins Dezan4 shared
Matthew J Morrison4 shared
Jeffrey B Moody4 shared
Dipesh K Shah3 shared
Brett R Havranek3 shared
Nicole E Knowlton2 shared
Full investigator report
Get the verbatim findings behind Kellia N Hicks' 434 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site